Everyday Health on MSN
How the new oral GLP-1 weight loss medications work
Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how next-gen “small molecule” drugs ...
The FDA has approved Eli Lilly's oral GLP-1, Foundayo. Let the heated rivalry with oral Wegovy begin
Eli Lilly announced this morning that the FDA has, as was expected, approved its oral GLP-1, orforglipron, as treatment for obesity and that it will market the pill as Foundayo. The pill version of ...
Dagens.com on MSN
Americans turn to pills over injections for weight loss
New oral weight-loss drugs are attracting growing interest in the United States, as patients look for more affordable and ...
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
The race to develop oral weight loss medications is intensifying as companies like Roche Holdings AG (OTC:RHHBY), Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), and Pfizer Inc (NYSE:PFE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results